USP tracks drug quality across world regions; FDA simplifies drug recall searches;

> The US Pharmacopeial Convention's Promoting the Quality of Medicines program has launched a database of medicines analyzed in various world regions prone to counterfeits and substandard drugs. Story

> The FDA now boasts a more consumer-friendly recall search engine that presents results in table format. Announcement | Recall Search Tool

> Methylphenidate HCl, a generic form of Ritalin, has been added to the FDA's drug shortages list; both Sandoz and Covidien report API constraints. List

> The FDA appears to be focusing on third-part inspections of foreign drug-making plants but ramping up for FDA agent inspections of medical device facilities. Article

> Germany's Glycotope Biotechnology is adding cleanroom facilities as a first step in expanding GMP-production capacity. Glycotype release

> The PharmaLine PQ UV disinfection system provides chemical-free disinfection for low-flow pharma and biotech applications. Release

> AAIPharma has built and moved into a purpose-built compendial raw materials testing area in its Wilmington, NC, headquarters. AAIPharma announcement

> Daiichi Sankyo has launched Kitasato Daiichi Sankyo Vaccine Co. to manufacture and market biological drug products. Daiichi release

> New GMP rules in China are likely to drive consolidation among the country's 5,000-plus drugmakers. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.